About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘oxford university press’ Category

Diabetes researcher who says he will no longer publish now up to five retractions

with 3 comments


Cory Toth, via U Calgary

Cory Toth, the University of Calgary diabetes researcher who told us last month he would stop publishing in science following a string of inappropriate manipulations, has retracted another paper.

Here’s the notice in Brain for “Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy:” Read the rest of this entry »

About these ads

Written by Ivan Oransky

May 28, 2014 at 9:30 am

Author who broke into lab to tamper with investigation now up to half a dozen retractions

leave a comment »

Bioconjugate ChemistryKarel Bezouška, the scientist who tried to tamper with an investigation into his work by breaking into a lab refrigerator, has had his fifth and sixth papers retracted.

Here’s the notice from Bioconjugate Chemistry for 2012′s “Dimerization of an Immunoactivating Peptide Derived from Mycobacterial hsp65 Using N-Hydroxysuccinimide Based Bifunctional Reagents Is Critical for Its Antitumor Properties:” Read the rest of this entry »

Film review by noted critic a rerun, retracted

with 3 comments

french cinemaMany devotees of French film consider Jean Renoir’s 1939 La Règle du jeu (The Rules of the Game) to be the best example of the genre, and indeed of movie making writ large.

Bad cut alert: One of the rules of the publishing game is, “ne pas plagier,” which we don’t think we need to translate here.

But that’s something that Robert Cardullo seems to have neglected. Cardullo, of Izmir University of Economics in Turkey, isn’t a nobody in the world of film criticism (you can say movie reviewing if you like, we won’t mind). Here’s a bio from Mellen Press: Read the rest of this entry »

Quickest withdrawal ever? Journal yanks paper alleging 800K deaths from Poldermans affair

with 9 comments

ehj Just 48 hours after publishing an article by Graham Cole and Darrel Francis last week alleging that Don Poldermans‘ scientific misconduct led to the deaths of some 800,000 Europeans over the past five years by tainting clinical guidelines, the European Heart Journal unceremoniously pulled the paper from its website Friday.

Larry Husten at CardioBrief has been on top of the story. According to Husten: Read the rest of this entry »

We did what? Authors retract paper after forgetting they’d published the same study elsewhere

with one comment

j antimicrob chemoScientists: Have you ever found it difficult to keep track of all those papers you publish? Who can blame you? So many journals, so much pressure to publish or perish.

That must have been what happened to a quintet of authors from Shanghai who’ve just had to retract an article from the Journal of Antimicrobial Chemotherapy. Here’s the notice (sadly, behind a paywall) [see note at end of post] for “Role of clofazimine in the treatment of multidrug-resistant tuberculosis: a retrospective observational cohort assessment:” Read the rest of this entry »

Another retraction for former record holder Joachim Boldt

leave a comment »

bjaWith all the fuss about Yoshitaka Fujii, the current record holder for most retractions, you can be forgiven for forgetting that Joachim Boldt once owned that title, at least for about a year.

Well, Boldt has another retraction, although he’d need to double his tally (which is in the range of 90) to match Fujii’s “impressive” haul.

The new paper is, well, old, having been published in 1996, some 14 years before Boldt’s tribulations began. The article was titled “Influence of different volume therapy regimens on regulators of the circulation in the critically ill.” It appeared in the British Journal of Anaesthesia, and has been cited 45 times, according to Thomson Scientific’s Web of Knowledge.

According to the notice: Read the rest of this entry »

Journal takes different tacks on two cancer papers with image problems

leave a comment »

carcinogenCarcinogenesis has the publishing world’s version of a twin problem: two dysfunctional articles yet one gets retracted while the other merely suffers a correction. Is it nature — or nurture?

Here are the details. One article, “Chemopreventive effect of dietary glutamine on colitis-associated colon tumorigenesis in mice,” came from a group in China. Published earlier this year, the authors seem to have had some trouble with their figures. As the corrigendum explains:  Read the rest of this entry »

Written by amarcus41

December 12, 2013 at 11:30 am

“Ambiguities in the presentation of some of the data” lead to an ambiguous retraction notice

with one comment

brainSometimes, authors and journals editors seem to think a bit of mystery is a good thing. Take a recent retraction in Brain.

Here’s the  notice for “Selective impairment of hand mental rotation in patients with focal hand dystonia:” Read the rest of this entry »

Plant journal withdraws paper — or does it?

with 2 comments

mol plantThe temporary withdrawal of a Molecular Plant paper had us scratching our heads, but the issue seems to be explained by a glitch.

If you click on this version of “Application of the CRISPR–Cas System for Efficient Genome Engineering in Plants” (subscription required), you see this:

This paper has been withdrawn pending a decision by the Editorial Board

But that page also says that the latest version of the paper was published on October 3. Clicking on that version sends you to the paper, which begins: Read the rest of this entry »

Written by Ivan Oransky

October 16, 2013 at 11:30 am

Aoki notches fourth retraction for image problems

with 11 comments

jbc1013We have a fourth retraction in the Journal of Biochemistry for Naohito Aoki, a Japanese researcher and former postdoc in a German lab, whose images have been called into question but whose retraction notices were scant. In this case, however, the journal, while not exactly overbrimming with information about the article, at least gives us some sense of what’s going on.

Aoki worked in the lab of Axel Ullrich, of the Max Planck Institute of Biochemistry, and appeared on two retracted articles in the Journal of Biological Chemistry (JBC) with his mentor, along with a third with a co-author from Japan, Tsukasa Matsuda. Although those notices don’t say anything about the reason for the retractions — this was before the JBC started providing such information — Ulrich told us that Aoki had been manipulating images. Read the rest of this entry »


Get every new post delivered to your Inbox.

Join 33,721 other followers